From Seekingalpha · SA Transcripts · · 40s
Disc Medicine Shares APOLLO Trial Results
Disc Medicine CEO reveals bitopertin trial success for EPP patients.
In brief
Disc Medicine CEO reveals bitopertin trial success for EPP patients. Disc Medicine reported positive top-line results from APOLLO Phase III trial of bitopertin for erythropoietic protoporphyria. Originally reported by Seekingalpha.
Company Announces Trial Results
Disc Medicine shares top-line results from APOLLO Phase III trial of bitopertin for erythropoietic protoporphyria.
CEO Discusses Findings
John Quisel, CEO, states the trial results are positive for patients with erythropoietic protoporphyria.
Next Steps for Treatment
Disc Medicine plans to discuss further data and potential regulatory submissions following the trial results.
The bottom line
Disc Medicine reported positive top-line results from APOLLO Phase III trial of bitopertin for erythropoietic protoporphyria.
